|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,230.00 IDR | +0.82% |
|
+2.93% | +2.07% |
| Dec. 24 | Kalbe Farma says Hale International to sell 2 plots of land in Curug village | RE |
| Dec. 12 | PT Kalbe Farma Tbk. announces an Equity Buyback for IDR 250,000 million worth of its shares. | CI |
| Capitalization | 55,739B 3.31B 2.84B 2.65B 2.46B 4.59B 299B 4.95B 30.46B 11.97B 143B 12.4B 12.15B 526B | P/E ratio 2025 * |
16.1x | P/E ratio 2026 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise value | 50.57B 3M 2.58M 2.4M 2.23M 4.17M 271M 4.49M 27.64M 10.86M 129M 11.25M 11.02M 478M | EV / Sales 2025 * |
1.45x | EV / Sales 2026 * | 1.31x |
| Free-Float |
40.21% | Yield 2025 * |
2.92% | Yield 2026 * | 3.25% |
| 1 day | +0.82% | ||
| 1 week | +2.93% | ||
| Current month | +2.07% | ||
| 1 month | +6.03% | ||
| 3 months | +13.36% | ||
| 6 months | -22.88% | ||
| Current year | +2.07% |
| 1 week | 1,180 | 1,235 | |
| 1 month | 1,165 | 1,255 | |
| Current year | 1,180 | 1,240 | |
| 1 year | 985 | 1,600 | |
| 3 years | 985 | 2,360 | |
| 5 years | 985 | 2,360 | |
| 10 years | 830 | 2,360 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-05-15 | |
Danny Natalies
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rustam Tan
SAM | Sales & Marketing | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Santoso Oen
BRD | Director/Board Member | 61 | 2007-12-31 |
Vidjongtius
CHM | Chairman | 61 | 2024-05-15 |
Ronny Hadiana
BRD | Director/Board Member | 54 | 2015-05-17 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.82% | +2.93% | -2.77% | -40.00% | 3.31B | ||
| -0.35% | +1.24% | +35.07% | +197.88% | 964B | ||
| +1.87% | +4.33% | +47.89% | +23.19% | 515B | ||
| +0.32% | -1.42% | +24.90% | +43.72% | 390B | ||
| +0.95% | +1.71% | +30.60% | +16.77% | 363B | ||
| +1.96% | +0.41% | +34.36% | +22.32% | 292B | ||
| +1.87% | +1.55% | +28.02% | +33.80% | 272B | ||
| -0.85% | -0.56% | +7.21% | -3.55% | 269B | ||
| -1.40% | +3.37% | -36.05% | -20.49% | 265B | ||
| -0.38% | -1.78% | +20.03% | +19.35% | 175B | ||
| Average | +0.39% | +1.50% | +18.93% | +29.30% | 350.84B | |
| Weighted average by Cap. | +0.34% | +1.56% | +26.46% | +67.98% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 34,885B 2.07B 1.78B 1.66B 1.54B 2.88B 187B 3.1B 19.06B 7.49B 89.31B 7.76B 7.6B 329B | 37,653B 2.23B 1.92B 1.79B 1.66B 3.1B 202B 3.35B 20.58B 8.08B 96.4B 8.38B 8.2B 356B |
| Net income | 3,560B 211M 181M 169M 157M 293M 19.07B 316M 1.95B 764M 9.11B 792M 776M 33.62B | 3,885B 230M 198M 185M 172M 320M 20.81B 345M 2.12B 834M 9.95B 864M 846M 36.68B |
| Net Debt | -5,167B -306M -263M -246M -228M -426M -27.68B -459M -2.82B -1.11B -13.23B -1.15B -1.13B -48.78B | -6,463B -383M -329M -307M -285M -533M -34.62B -574M -3.53B -1.39B -16.55B -1.44B -1.41B -61.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-14 | 1,230.00 Rp | 0.00% | 45,697,500 |
| 26-01-13 | 1,230.00 Rp | +0.82% | 39,389,900 |
| 26-01-12 | 1,220.00 Rp | +2.95% | 60,842,500 |
| 26-01-09 | 1,185.00 Rp | -0.42% | 19,865,000 |
| 26-01-08 | 1,190.00 Rp | -0.42% | 40,194,800 |
End-of-day quote INDONESIA S.E., January 12, 2026
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KLBF Stock
Select your edition
All financial news and data tailored to specific country editions
















